EUCTR2006-005772-41-NL进行中（未招募）不适用
IMIT: Lowering the Incidence of vascular complications with Metformin in patients with Impaired glucose tolerance and a recent TIA or minor ischemic stroke: a phase 2, randomized, controlled trial - LIMIT phase 2
investigator-driven research: Erasmus MC, Neurovascular Section0 个研究点目标入组 40 人开始时间: 2006年10月20日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-Age > 18 years
- •-TIA/minor ischemic stroke < 6 months
- •-Non-diabetics with impaired glucose tolerance (2hr post-load glucose 7.8-11.0 mmol/L) or impaired fasting glucose (fasting glucose 5.6-6.9 mmol/L)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-Diabetes mellitus
- •-Dependency of others (mRankin = 4)
- •-Contraindication metformin (severe renal failure, severe hepatic insufficiency, severe heart failure, severe hypoxic lung disease, lactic acidosis in history)
- •-Severe comorbidity interfering with follow-up
- •-Pregnancy or breast feading
研究者
相似试验
招募中
2 期
IMIT: Lowering the Incidence of vascular complications with Metformin in patients with Impaired glucose tolerance and a recent TIA or minor ischemic stroke: a phase 2, randomized, controlled trialprediabetesimpaired glucose tolerance1001842410007963NL-OMON30741Erasmus MC, Universitair Medisch Centrum Rotterdam40
已完成
不适用
IMIT-1: Lowering the Incidence of vascular complications with Metformin in patients with Impaired glucose Tolerance and a recent transient ischaemic attack or minor ischaemic stroke: a phase II randomised, controlled trialTransient ischaemic attack or minor ischaemic strokeCirculatory SystemVascular complicationsISRCTN54960762Erasmus Medical Centre (The Netherlands)40
招募中
不适用
IMIT-1: Lowering the Incidence of vascular complications with Metformin in patients with Impaired glucose tolerance and a recent TIA or minor ischemic stroke: a phase 2, randomized, controlled trialglucose intolerancemetforminTIAstroke, ischemictrialNL-OMON26223S.E. Vermeer, MD, PhD40
已完成
不适用
Improving the prevention of vascular events after stroke or transient ischemic attackStrokeISRCTN63816609Royal Devon and Exeter Foundation Trust (UK)30
进行中（未招募）
不适用
Discovering beneficial properties of ticagrelor in acute myocardialinfarctioST elevation myocardial infarction (STEMI)EUCTR2014-005363-33-ESVU university medical center110